These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32855828)
1. A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed. Steinmetz-Wood S; Gilbert M; Menson K Case Rep Endocrinol; 2020; 2020():8832833. PubMed ID: 32855828 [TBL] [Abstract][Full Text] [Related]
2. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip. Zughaib MT; Patel K; Leka M; Affas S Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838 [TBL] [Abstract][Full Text] [Related]
3. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature. Mistry S; Eschler DC AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013 [TBL] [Abstract][Full Text] [Related]
4. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists. Kang CY; Khamooshi P; Reyes Pinzon V Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514 [TBL] [Abstract][Full Text] [Related]
5. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old. Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482 [TBL] [Abstract][Full Text] [Related]
6. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report. Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826 [TBL] [Abstract][Full Text] [Related]
7. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections? Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692 [TBL] [Abstract][Full Text] [Related]
8. Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor. Alhemeiri M; Alseddeeqi E Case Rep Endocrinol; 2022; 2022():4101975. PubMed ID: 35282610 [TBL] [Abstract][Full Text] [Related]
9. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor. Allison R; Goldstein D; Musso MW J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990 [TBL] [Abstract][Full Text] [Related]
10. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report. Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997 [TBL] [Abstract][Full Text] [Related]
11. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports. Altowayan WM Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864 [TBL] [Abstract][Full Text] [Related]
12. Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis. Sell J; Haas NL; Korley FK; Cranford JA; Bassin BS West J Emerg Med; 2023 Nov; 24(6):1049-1055. PubMed ID: 38165186 [TBL] [Abstract][Full Text] [Related]
13. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report. Brown F; McColl T J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798 [TBL] [Abstract][Full Text] [Related]
14. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Diaz-Ramos A; Eilbert W; Marquez D Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052 [TBL] [Abstract][Full Text] [Related]
15. Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians? Somagutta MKR; Uday U; Shama N; Bathula NR; Pendyala S; Mahadevaiah A; Mahmutaj G; Ngardig NN Korean J Fam Med; 2022 Nov; 43(6):361-366. PubMed ID: 36444120 [TBL] [Abstract][Full Text] [Related]
16. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature. Gajjar K; Luthra P Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148 [TBL] [Abstract][Full Text] [Related]
17. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet. Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617 [TBL] [Abstract][Full Text] [Related]
18. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin! Kamath SD; Kumar U; Shrivastava V Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291 [TBL] [Abstract][Full Text] [Related]
19. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report. Alkatheeri A; Alseddeeqi E J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357 [TBL] [Abstract][Full Text] [Related]
20. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery. Osafehinti DA; Okoli OJ; Karam JG AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]